Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaxCyte Regulatory News (MXCT)

  • There is currently no data for MXCT

Block listing Interim Review

1 Feb 2018 16:06

RNS Number : 6932D
MaxCyte, Inc.
01 February 2018
 

SCHEDULE 6

AIM BLOCK ADMISSION SIX MONTHLY RETURN

 

Please ensure the entries on this return are typed

 

a. Name of company

 

MaxCyte, Inc.

 

b. Name of scheme(s)

 

MaxCyte Long Term Incentive Plan

 

c. Period of return:

 

From 5 May 2017 To 31 January 2018

 

d. Number and class of securities not issued under scheme

 

1,000,000 ordinary shares of common stock of $0.01 each

 

e. Number of shares issued under scheme during period

 

200,229 ordinary shares of common stock of $0.01 each

 

f. Balance under the scheme not yet issued at the end of the period.

 

799,771 ordinary shares of common stock of $0.01 each

 

g. Number and class of share(s) (amount of stock / debt securities) originally listed and the date of admission; If additional blocklisting application have been made, under this scheme, since the original listing application please also state the number of shares and the date(s) of admission.

 

1,000,000 ordinary shares of common stock of $0.01 each on 5 May 2017

 

Please confirm your total issued share capital as at the end of this period.

(If you hold any shares in Treasury state the figure separately);

 

……51,014,746……………… Treasury shares (if applicable) ………Nil………….

 

h. Contact name and telephone number for queries;

 

Doug Doerfler, Chief Executive Officer

Ron Holtz, Chief Financial Officer

+1 301 944 1660

 

Date

 

1 February 2018

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BLRUARNRWUAURAR
Date   Source Headline
26th Jun 20257:00 amRNSCancellation - Maxcyte Inc
25th Jun 20257:00 amRNSLast Day of Dealings on AIM
23rd Jun 20256:00 pmRNSMaxCyte
19th Jun 20257:00 amRNSResult of Annual General Meeting
12th Jun 20257:00 amRNSHolding(s) in Company
11th Jun 20257:00 amRNS-RMaxCyte and Ori Biotech Announce Collaboration
6th Jun 20259:33 amRNSHolding(s) in Company
5th Jun 20252:16 pmRNSHolding(s) in Company
2nd Jun 20255:14 pmRNSTotal Voting Rights
2nd Jun 20254:17 pmRNSHolding(s) in Company
29th May 20257:06 amRNSHolding(s) in Company
23rd May 20254:52 pmRNSHolding(s) in Company
23rd May 20254:26 pmRNSHolding(s) in Company
23rd May 20257:00 amRNSHolding(s) in Company
19th May 20256:05 pmRNSHolding(s) in Company
16th May 20253:12 pmRNSHolding(s) in Company
9th May 20257:00 amRNSFiling of Form 10-Q
8th May 20257:00 amRNSFirst Quarter 2025 Financial Results
2nd May 20254:40 pmRNSTotal Voting Rights
28th Apr 20257:00 amRNSFiling of definitive proxy statement
22nd Apr 20252:43 pmRNSHolding(s) in Company
22nd Apr 20252:37 pmRNSHolding(s) in Company
15th Apr 20255:00 pmRNSHolding(s) in Company
15th Apr 20257:00 amRNSProposed cancellation of trading on AIM
14th Apr 20259:17 amRNSHolding(s) in Company
10th Apr 20257:00 amRNSMaxCyte to Report Q1 2025 Results on May 7, 2025
8th Apr 20253:35 pmRNSHolding(s) in Company
1st Apr 20255:57 pmRNSTotal Voting Rights
26th Mar 202510:14 amRNSCorrection: Vesting of RSUs and PDMR Dealing
26th Mar 20257:00 amRNSVesting of RSUs and PDMR Dealing
25th Mar 202510:30 amRNSHolding(s) in Company
25th Mar 202510:28 amRNSHolding(s) in Company
25th Mar 202510:26 amRNSHolding(s) in Company
25th Mar 202510:22 amRNSHolding(s) in Company
24th Mar 20259:06 amRNSGrant of Options, RSUs and PSUs and PDMR Dealing
19th Mar 20252:07 pmRNSHolding(s) in Company
12th Mar 20257:01 amRNSFiling of Form 10-K for FY ended December 31, 2024
12th Mar 20257:00 amRNSQ4 & FY 2024 Financial Results
4th Mar 20253:38 pmRNSTotal Voting Rights
19th Feb 20253:23 pmRNSHolding(s) in Company
14th Feb 20255:05 pmRNSHolding(s) in Company
13th Feb 20254:12 pmRNSHolding(s) in Company
13th Feb 20252:52 pmRNSHolding(s) in Company
12th Feb 20257:00 amRNSStrategic Platform License with TG Therapeutics
7th Feb 20257:00 amRNSNotice of Results
4th Feb 20257:00 amRNSTotal Voting Rights
31st Jan 20253:18 pmRNSExercise of options and PDMR dealing
30th Jan 20257:00 amRNSMaxCyte® Acquires SeQure Dx
29th Jan 20253:05 pmRNSHolding(s) in Company
22nd Jan 20252:25 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.